Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.04 - $1.9 $23,241 - $42,461
-22,348 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.46 - $2.82 $4,139 - $7,994
-2,835 Reduced 11.26%
22,348 $41,000
Q3 2021

Nov 12, 2021

SELL
$3.81 - $6.76 $183,657 - $325,859
-48,204 Reduced 65.68%
25,183 $96,000
Q2 2021

Aug 12, 2021

BUY
$6.28 - $16.2 $460,870 - $1.19 Million
73,387 New
73,387 $509,000

Others Institutions Holding ONTX

About Onconova Therapeutics, Inc.


  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.